Structures by: Gou G. Z.
Total: 9
C17H15N3O,0.5(H2O)
C17H15N3O,0.5(H2O)
Organic letters (2012) 14, 20 5226-5229
a=25.865(5)Å b=7.4047(15)Å c=15.416(3)Å
α=90.00° β=97.89(3)° γ=90.00°
C19H19BF2N4O
C19H19BF2N4O
Organic letters (2012) 14, 20 5226-5229
a=13.339(3)Å b=18.975(4)Å c=6.8571(15)Å
α=90.00° β=90.00° γ=90.00°
C19H13BF8N4O
C19H13BF8N4O
Organic letters (2012) 14, 20 5226-5229
a=10.873(3)Å b=14.773(4)Å c=11.623(3)Å
α=90.00° β=92.752(4)° γ=90.00°
C17H14BF2N3O
C17H14BF2N3O
Organic letters (2012) 14, 20 5226-5229
a=18.636(4)Å b=10.788(2)Å c=15.333(3)Å
α=90.00° β=94.98(3)° γ=90.00°
C26H32Br2N4
C26H32Br2N4
RSC Advances (2013) 3, 18 6334
a=18.050(4)Å b=6.7540(14)Å c=21.429(4)Å
α=90.00° β=90.00° γ=90.00°
C28H36Br2N4
C28H36Br2N4
RSC Advances (2013) 3, 18 6334
a=14.276(3)Å b=9.1205(18)Å c=13.007(3)Å
α=90.00° β=113.75(3)° γ=90.00°
C27H36Br2N4O
C27H36Br2N4O
RSC Advances (2013) 3, 18 6334
a=6.8588(14)Å b=18.823(4)Å c=22.137(4)Å
α=90.00° β=93.85(3)° γ=90.00°
<i>N</i>-(7-Dibromomethyl-5-methyl-1,8-naphthyridin-2-yl)acetamide-- pyrrolidine-2,5-dione (1/1)
C12H11Br2N3O,C4H5NO2
Acta Crystallographica Section E (2013) 69, 2 o153-o154
a=11.537(2)Å b=7.0093(14)Å c=11.632(2)Å
α=90.00° β=106.57(3)° γ=90.00°
<i>N</i>-(7-Methyl-1,8-naphthyridin-2-yl)acetamide--acetic acid (1/1)
C11H11N3O1,C2H4O2
Acta Crystallographica Section E (2013) 69, 4 o489
a=8.3628(17)Å b=9.0904(18)Å c=9.5093(19)Å
α=71.30(3)° β=76.43(3)° γ=78.64(3)°